Award
National Institute of Allergy and Infectious Diseases 3R01AI195133-01S1
Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (HISTO-FACT)
Recipient
University of Minnesota
Award Amount
$348,689.00
Ceiling
$348,689.00
Awarded
September 05, 2025
Identifier
3R01AI195133-01S1
A NIH-funded clinical trial to compare new induction and consolidation therapies for histoplasmosis in HIV patients, aiming to improve treatment safety, efficacy, and affordability.
Description
This project aims to evaluate new therapeutic strategies through a large phase III, factorial design clinical trial to improve treatment guidelines for histoplasmosis, focusing on safety, efficacy, and cost-effectiveness.